GlaxoSmithKline PLC (NYSE:GSK)

40.21
BATS BZX Real-Time Price
As of 10:20am ET
 -0.42 / -1.03%
Today’s Change
36.41
Today|||52-Week Range
42.32
+5.23%
Year-to-Date
Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up
Jun 21 / Zacks.comZAK - Paid Partner Content
Merck's Keytruda Gets 2nd Label Expansion Approval in June
Jun 19 / Zacks.comZAK - Paid Partner Content
Sphera Funds Management Ltd. Buys Johnson & Johnson, Novo Nordisk A/S, Bristol-Myers ...
Jun 20 / GuruFocus NewsGURU - Paid Partner Content
Sanofi Partners Google to Build Healthcare Innovation Lab
Jun 18 / Zacks.comZAK - Paid Partner Content
AstraZeneca's Triple-Combo COPD Inhaler Gets Japan's Nod
Jun 20 / Zacks.comZAK - Paid Partner Content
Glaxo Inks Genome Research Deal With University of California
Jun 14 / Zacks.comZAK - Paid Partner Content
Gilead (GILD) Teams Up With Nurix for Cancer and Other Drugs
Jun 20 / Zacks.comZAK - Paid Partner Content
Matinas BioPharma to Present at the 9th Annual LD Micro Invitational
Jun 03 / GlobeNewswirePNW - Paid Partner Content

Today’s Trading

Previous close40.63
Today’s open40.42
Day’s range40.17 - 40.43
Volume210,626
Average volume (3 months)2,374,131
Market cap$100.4B
Data as of 10:20am ET, 06/26/2019

Growth & Valuation

Earnings growth (last year)+143.10%
Earnings growth (this year)-8.04%
Earnings growth (next 5 years)+3.85%
Revenue growth (last year)+5.72%
P/E ratio20.2
Price/Sales2.31
Price/Book17.85

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+1.71+2.60%
SNYSanofi-0.51-1.17%
AZNAstraZeneca-0.59-1.43%
NVONovo Nordisk-0.35-0.68%
Data as of 10:20am ET, 06/26/2019

Financials

Next reporting dateJuly 24, 2019
EPS forecast (this quarter)$0.64
Annual revenue (last year)$41.1B
Annual profit (last year)$4.8B
Net profit margin11.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Iain James Mackay
Corporate headquarters
Brentford, Greater London

Forecasts